Production (Stage)
Crinetics Pharmaceuticals, Inc.
CRNX
$31.37
-$0.405-1.28%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -5.90% | 56.96% | -0.03% | -4.22% | 61.30% |
| Total Receivables | -13.65% | 22.12% | 39.25% | -46.59% | 0.70% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -49.67% | 70.87% | 41.73% | 52.32% | -38.02% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 80.46% | 28.78% | -25.87% | -38.36% | 131.64% |
| Total Current Assets | -6.13% | 56.72% | 0.32% | -4.63% | 59.75% |
|
|
|||||
| Total Current Assets | -6.13% | 56.72% | 0.32% | -4.63% | 59.75% |
| Net Property, Plant & Equipment | -0.46% | -0.72% | -2.24% | -0.64% | 0.34% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 694.97% | -10.05% | 20.57% | 15.54% | -60.61% |
| Total Assets | -5.11% | 53.04% | 0.20% | -4.36% | 53.95% |
|
|
|||||
| Total Accounts Payable | 68.15% | 18.51% | -44.33% | -17.52% | 64.26% |
| Total Accrued Expenses | -13.74% | 13.26% | 10.72% | 18.94% | 9.07% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -3.76% | -3.52% | -0.43% | 28.54% | 38.80% |
| Total Finance Division Other Current Liabilities | 0.91% | 13.50% | -25.32% | -52.14% | -8.23% |
| Total Other Current Liabilities | 0.91% | 13.50% | -25.32% | -52.14% | -8.23% |
| Total Current Liabilities | -3.98% | 11.43% | -1.50% | 5.04% | 17.81% |
|
|
|||||
| Total Current Liabilities | -3.98% | 11.43% | -1.50% | 5.04% | 17.81% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.42% | -1.23% | -1.63% | -1.80% | -1.77% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 9.89% | -3.03% | 26.18% | -4.62% | -0.19% |
| Total Liabilities | -2.24% | 5.17% | -0.36% | 1.50% | 7.24% |
|
|
|||||
| Common Stock & APIC | 1.10% | 33.69% | 4.73% | 1.89% | 33.86% |
| Retained Earnings | -10.16% | -9.25% | -9.67% | -10.28% | -10.24% |
| Treasury Stock & Other | 107.89% | -52.75% | 1,172.63% | -226.67% | -84.65% |
| Total Common Equity | -5.34% | 59.04% | 0.27% | -5.05% | 62.29% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.34% | 59.04% | 0.27% | -5.05% | 62.29% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.34% | 59.04% | 0.27% | -5.05% | 62.29% |
|
|
|||||